Ahmed Salem, PhD (he/him/his)

Senior Scientist
AsztraZeneca

Poster(s):

• (M-001) Prediction of Percent Free Nerve Growth Factor Suppression following Administration of MEDI7352, a Bispecific Fusion Protein for Dual Targeting of NGF and TNFα, in Patients with Painful Diabetic Neuropathy and Osteoarthritis
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT

• (M-002) Population Pharmacokinetic Modeling of MEDI7352, a Bispecific Fusion Protein for Dual Targeting of NGF and TNFα, in Patients with Painful Diabetic Neuropathy and Painful Osteoarthritis of the Knee
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT